ArticleActa Cardiologica Sinica2022

Real-World Data on Comparison of Lipid-Lowering Effects between Alirocumab and Evolocumab in Patients with Hypercholesterolemia.

Dai-Yi Lin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.